BIBLIOGRAFIA
Abbasinazari M., Hajhossein Talasaz A., Eshraghi A., Sahraei Z.. Detection and management of medication errors in internal wards of a teaching hospital by clinical pharmacists. Acta Med Iran 2013; 51(7):482–486.
Adeyl, O., Smith, O., & Robles, S.. Public policy and the challenge of chronic noncommunicable diseases. Washington D.C., World Bank, 2007.
Al Mazroui N.R., Kamal M.M., Ghabash N.M., Yacout T.A., Kole P.L., McElnay J.C.. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67(5):547–557.
Al-Rashed S.A., Wright D.J., Roebuck N., Sunter W., Chrystyn H.. The value of inpatient pharmaceutical counseling to elderly patients prior to discharge. Br J Clin Pharmacol 2002; 54(6):657–664.
Aljboury T.M., Alkhawaldeh M.S, Abu-Rumman Ala’a eddeen K, Hasan T.A., Khattar H.M., Abu-Oliem A.S.. Impact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharmaceutical Journal 2013; 21(4):371-374.
Allemann S.S., van Mil J.W.F., Botermann L., Berger K., Griese N., Hersberger K.E.. Pharmaceutical Care: the PCNE definition 2013. Int J Clin Pharm Jun 2014; 36(3):544–555.
Altowaijri A., Phillips C.J., Fitzsimmons D.. A Systematic Review of the Clinical and Economic Effectiveness of Clinical Pharmacist Intervention in Secondary Prevention of Cardiovascular Disease. J Manag Care Pharm. Jun 2013;
19(5):408-416.
American Pharmacists Association. National Association of Chain Drug Stores
Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;
48(3):341–53 (Epub 2008/07/04).
Anderson C., Bates I., Beck D., Brock T., Futter B., Mercer H., Rouse M., Wuliji T., Yonemura A.. The WHO UNESCO FIP Pharmacy Education. Am J Pharm Educ 2008 Dec 15; 72(6):127.
Anderson S.. The state of the worlds pharmacy: a portrait of the pharmacy profession. Journal of Interprofessional Care Nov 2002;16(4):391-404.
Ambardekar A.V., Fonarow G.C., Hernandez A.F., Pan W., Yancy C.W., Krantz M.J.. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from the Get With The Guidelines-Heart Failure (GWTG- HF). Am Heart J. 2009;158(4):644-52.
Annema C., Luttik M.L., Jaarsma T.. Reasons for readmission in heart failure:
perspectives of patients, caregivers, cardiologists, and heart failure nurses. Heart Lung. 2009;38(5):427-34.
Antoine S.L, Pieper D., Mathes T., Eikermann M.. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocrine Disorders 2014 Jul 7; 14:53 doi:
10.1186/1472-6823-14-53.
Azhar S., Hassali M.A., Ibrahim M.I., Ahmad M., Masood I., Shafie A.A.. The role of pharmacists in developing countries: the current scenario in Pakistan.
Human
Resourc for Health 2009 Jul 13; 7:54. doi: 10.1186/1478-4491-7-54.
Badger F., Kingscote-Davies T., Nolan P.. The pharmacist’s role in the medicinal management of depression. Nursing Standard 2002 Aug 7-13; 16(47):33–40.
Bagole LE, Beaumont A, Morgan I.. Outcomes of medicines use reviews for people with asthma. Int J Pharm Pract 2007; 15 Suppl 2:B66.
Barber N.. Pharmaceutical care and medicines management, is there a difference? Pharm World Sci 2001 Dec; 23(6):205-209.
Behmane D., Innus J.. Pharmaceutical policy and the effects of the economic crisis: Latvia. Eurohealth 2011; 4:69-79.
Bell S., McLachlan A.J., Aslani P., Whitehead P., Chen T.F.. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Australia and New Zealand Health Policy 2005 Dec 7; 2:29.
Berenguer B., Lacasa C., de La Matta M.J, Martin-Calaro M.J.. Pharmaceutical care: Past, Present and Future. Journal of Current Pharmaceutical Design 2004;
10(31): 3931-3946.
Bolas H., Brookes K., Scott M., McElnay J.. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci 2004;
26(2):114–120.
Bouvy M.L., Heerdink E.R., Urquhart J., Grobbee D.E., Hoes A.W., Leufkens H.G.. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail 2003; 9(5):404-11.
Boyko W.L. Jr, Yurkowski P.J., Ivey M.F., Armitstead J.A., Roberts B.L..
Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997 Jul 15; 54(14):1591–1595.
Brook O.H., van Hout H.P.J., Nieuwenhuysea H., De Haan M.. Effects of coaching by community pharmacists on psychological symptoms of
antidepressant users, a randomised controlled trial. European Neuropsychopharmacology 2003 Oct; 13(5): 347-354.b
Brook O.H., van Hout H.P.J., Nieuwenhuyse H., Heerdink E.. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. European Neuropsychopharmacology 2003 Jan; 13(1):1-9.a
Brook O.H., Van Hout H.P.J., Stalman W., Nieuwenhuyse H., Bakker B., Heerdink E., De Haan M.. A pharmacy based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatric Services 2005 Apr; 56(4):487-489.
Brown J.P., Josse R.G.. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002 Nov 12; 167(10 suppl):S1–
S34.
Bunting B.A., Cranor C.W.. The Asheville Project: long-‐term clinical, humanistic, and economic outcomes of a community-‐based medication therapy management program for asthma. J Am Pharm Assoc (2003) 2006 Mar-‐Apr;
46(2):133-‐147.
Bunting B.A., Smith B.H., Sutherland S.E.. The Asheville Project: clinical and economic outcomes of a community-‐based long-‐term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) Jan-‐Feb 2008; 48(1):23-‐31.
Burke L.E., Dunbar-Jacob J.. Adherence to medication, diet, and activity recommendations: from assessment to maintenance. J Cardiovasc Nurs 1995 Jan;
9(2):62–79.
Buurma H., de Smet P.A.G.M., van den Hoff O.P., Egberts A.C.G.. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001 Jul; 52(1):85–91.
Caamaño F., Alvarez R., Khoury M.. The community pharmacists and their practice as health care providers. Gac Sanit. 2008; 22(4):385.
Caamaño F., Ruano A., Figueiras A., Gestal-Otero J.J.. Data collection methods for analyzing the quality of the dispensing in pharmacies. Pharm World Sci.
2002; 24(6):217-223.
Cai H., Dai H., Hu Y., Yan X., Xu H.. Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials.
BMC Health Services Research 2013 Nov 4; 13:461 doi: 10.1186/1472-6963-13- 461.
Calvert S.B., Kramer J.M., Anstrom K.J., Kaltenbach L.A., Stafford J.A., Allen LaPointe N.M.. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J 2012; 163(4):657–
665.
Capgemini Consulting. Patient Adherence: The Next Frontier in Patient Care, Paris, Vision and Reality 9th ed., May 2011.
Carter B.L., Ardery G., Dawson J.D., James P.A., Bergus G.R., Doucette W.R., Chrischilles E.A., Franciscus C.L., Xu Y.. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;
169(21):1996–2002.b
Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ.. A cluster randomized trial to evaluate physician/pharmacist
collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008 Apr; 10(4):260–271.
Carter B.L., Rogers M., Daly J., Zheng S., James P.A.. The potency of team- based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009; 169(19):1748–1755.a
Carter B.L., van Mil Foppe J.W.. Comparative Effectiveness Research:
Evaluating Pharmacist Interventions and Strategies to Improve Medication Adherence. American Journal of Hypertension 2010 Sep; 23(9):949-955 doi:
10.1038/ajh.2010.136. Epub 2010 Jul 22.
Chamba G., Bauguil G., Galiezot J.. The role of the French community pharmacist in drug dispensing. Pharm World Sci 1999; 21(3):142–143.
Chan C.W., Siu S.C., Wong C.K., Lee V.W.. A pharmacist care program:
positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther Mar 2012; 17(1):57–64.
Chan FW, Wong FY, So WY, Kung K., Wong C.K... How much do elders with chronic conditions know about their medications? BMC Geriatr 2013 Jun 13;
13:59. doi: 10.1186/1471-2318-13-59.
Chang E, Daly J, Bell P, Brown T, Allan J, Hancock K.. A continuing educational initiative to develop nurses' mental health knowledge and skills in rural and remote areas. Nursing Education Today 2002 Oct; 22(7):542-551.
Chisholm-Burns M.A., Lee J.K., Spivey C.A., Slack M., Herrier R.N., Hill-Lipsy E., Zivin J.G., Abrahm I., Palmer J., Martin J.R., Kramer S.S., Wunz T.. U.S.
Pharmacists’ effects as team members on patient care: Systematic review and meta-analysis. Med Care 2010 Oct; 48(10):923–933.
Chong J., Karner C., Poole P.. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012 Sep 12;9:CD009157. doi: 10.1002/14651858. pub2.
Choo P.W., Rand C.S., Inui T.S., Lee M.L., Cain E., Cordeiro-Breault M., Canning C., Platt R.. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999 Sep; 37(9):846–857.
Chowdhury R., Khan H., Heydon E., Shroufi A., Fahimi S., Moore C., Stricker B., Mendis S., Hofman A., Mant J., Franco OH.. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013 Oct; 34(38):2940-2948.
Christensen D., Trygstad T., Sullivan R., Garmise J., Wegner S.E.. A Pharmacy management intervention for optimizing drug therapy for nursing home patients.
Am J Geriatr Pharmacother. 2004 Dec; 2(4):248-256.
Chumney E.C., Robinson L.C.. The effects of pharmacist interventions on patients with polypharmacy. Pharmacy Practice 2006; 4(3):103-109.
Cipolle R.J., Strand L.M., Morley P.C.. Pharmaceutical Care Practice, New York, McGraw Hill, 1998.a
Cipolle R.J., Strand L.M., Morley P.C.. Pharmaceutical Care Practice: The Clinician's Guide, McGraw-Hill Medical Publishing Division 2nd edition, 25 May 2004.
Cipolle R.J., Strand L.M., Morley P.C.. Pharmaceutical Care Practice, Minneapolis, McGraw- Hill, 1998.b
Clifford R.M., Davis W.A., Batty K.T., Davis T.M.. Fremantle Diabetes Study.
Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005 Apr; 28(4):771–776.
Clifford S., Garfield S., Eliasson L., Barber N.. Medication adherence and community pharmacy: a review of education, policy and research in England.
Pharmacy Practice (Granada) 2010 Apr-Jun; 8(2):77-88.
Commission to Implement Changes in Pharmaceutical Education. Entry level education in pharmacy, a commitment to change, in Penna R.P. ed. The Papers of the Commission to Implement Change in Pharmaceutical Education, Alexandria, VA: American Association of Colleges of Pharmacy, 1994, pp. 35-58. a
Commission to Implement Changes in Pharmaceutical Education. The responsibility of pharmaceutical education for scholarships, graduate education, fellowships and postgraduate professional education and training, in Penna R.P.
ed. The Papers of the Commission to Implement Change in Pharmaceutical Education, Alexandria, VA: American Association of Colleges of Pharmacy 1994; pp. 59-97. b
Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007;
24(2):189–200.
Corden ZM, Bosley CM, Rees PJ, Cochrane GM.. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997; 112(5):1278–1282.
Cordina M., McElnay J.C., Hughes C.M.. Assessment of a community pharmacy- based program for patients with asthma. Pharmacotherapy 2001 Oct;
21(10):1196-1203.
Cramer J.A., Okikawa J., Bellaire S., Clauson P.. Compliance with inhaled insulin treatment using the AERx (registered trademark) iDMS insulin diabetes management system. Diab Technol Ther 2004; 6(6):800–807.
Cranor C.W., Christensen D.B.. The Asheville Project: short-‐term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003 Mar-‐Apr; 43(2):149-159.
Crealey G.E., Sturgess I.K., McElnay J.C., Hughes C.M.. Pharmaceutical care programmes for the elderly: economic issues. Pharmacoeconomics 2003; 21(7):
455–465.
Davis E.M., Packard K.A., Jackevicius C.A.. The Pharmacist Role in Predicting and Improving Medication Adherence in Heart Failure Patients. J Manag Care Pharm. 2014; 20(7):741-55.
Denig P., Wahlstrom R., De Saintonge M.C., Haaijer-Ruskamp F.. The value of clinical judgement analysis for improving the quality of doctors’ prescribing decisions. Med Educ 2002 Aug; 36(8):770–780.
Department of Health. Pharmacy in England: building on strengths – delivering the future, London, Department of Health, 2008.
DiMatteo M.R.. Variations in patients’ adherence to medical recommendations:
a quantitative review of 50 years of research. Med Care 2004; 42(3):200–209.
Donato R., March G., Moss J., Gilbert A.. Cost implications of the delivery of pharmaceutical care services through Australian community pharmacies. Int J Pharm Pract 2001; 9(1):23-30.
Doucette W.R., McDonough R.P., Klepser D., McCarthy R.. Comprehensive medication therapy management: identifying and resolving drug-related issues in
a community pharmacy. Clin Ther 2005; 27(7):1104-1111.
Drug use in the elderly. Prescribing practice review, Sydney, National Prescribing Service Ltd, 2004.
Edelman D., Fredrickson S.K., Melnyk S.D., Coffman C.J., Jeffreys A.S., Datta S., Jackson G.L., Harris A.C., Hamilton N.S., Stewart H., Stain J., Weinberger M.. Medical clinics versus usual care for 809 patients with both diabetes and hypertension: a randomized trial. Ann Intern Med 2010 Jun 1; 152(11):689–696.
Elias M.N., Burden A.M., Cadarette S.M.. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporos Int 2011 Oct; 22(10):2587–2596. DOI 10.1007/s00198-011-1661-7.
Elliot R.. Non-adherence to medicines: not solved but solvable. J Health Serv Res Policy 2009; 14(1):58–61.
Farris K.B., Fernandez-Llimos F., Benrimoj S.I.. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother 2005 Sep; 39(9):1539-1541.
Faulkner M.A., Wadibia E.C., Lucas B.D., Hilleman D.E.. Impact of pharmacy counseling on compliance and effectiveness of combination lipid- lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy 2000; 20(4):410–416.
Federazione degli Ordini dei Farmacisti Italiani. Il farmacista italiano è pronto a un ruolo più ampio: lo provano i dati. www.fofi.it 8 Febbraio 2013. WEB.
Accessed 8 Marzo 2016. URL http://www.fofi.it/news.php?id=1745
Finley P.R., Crimson M.L., Rush A.J.. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003 Dec; 23(12):1634-
1644.
Fornos J.A., Andrés N.F., Andrés J.C., Guerra M.M., Egea B.. A pharmacotherapy follow- up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci 2006 Apr; 28(2):65–72.
Forster A.J., Clark H.D., Menard A., Dupuis N., Chernish R., Chandok N., Khan A., van Walraven C.. Adverse events among medical patients after discharge from hospital. CMAJ. 2004; 170(3):345–9.
Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., Bates D.W.. The incidence and severity of adverse events affecting patients after discharge from the hospital.
Ann Intern Med. 2003; 138(3):161–167.
Gallefoss F. The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Educ Couns. 2004;52(3):259–66.
Gallefoss F., Bakke P.S., Rsgaard P.K. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Mar; 159(3): 812–7.
Galt K.A. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center.
Pharmacotherapy 1998;18(5):1103-1111.
Garcão J.A., Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc 2002 Nov-Dec; 42(6):
858–64.
Garfield R. Usa and shortage of food and medicine in Cuba. Lancet 1997 Feb 1;
349(9048):363.
Garuoliene K., Alonderis T., Marinkevicius M. Eurohealth: Pharmaceutical policy and the effects of the economic crisis: Lithuania. Eurohealth 2011;17(1):1- 4.
Gerdemann A., Mueller U., Schulz M. Akzeptanz und Evaluation derzertifizierten Diabetes Fortbildung [Acceptance and evaluation of the certified diabetes training]. PharmZtg. 2004;149(46):4052-4054.
Geurts M.M., van der Flier M., de Vries-Bots A.M., Brink-van der Wal T.I., de Gler J.J. Medication reconciliation to solve discrepancies in discharge documents after discharge from the hospital. Int J Clin Pharm 2013 Aug; 35(4):600–607.
Giberson S., Yoder S., Lee M.P. Improving Patient and Health System Outcomes through Advanced Pharmacy Practice. A Report to the U.S. Surgeon General.
Office of the Chief Pharmacist. U.S. Public Health Service. Dec 2011.
Gibson G.J., Loddenkemper R., Lundbäck B., Sibille Y. The european lung white book: respiratory health and disease in Europe. In: The economic burden of lung disease. European Respiratory Society, 2013, pp 16-27.
Go A.S, Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics—
2013 update: a report from the American Heart Association. Circulation.
2013;127(1): 6-245.
Goodyer L.I., Miskelly F., Milligan P. Does encouraging good compli- ance improve patients’ clinical condition in heart failure? Br J Clin Pract.
1995;49(4):173-76.
Gorgas T.M.Q., Pa`ez V.F., Camo ́s R.J., Jolonch S.P., Homs P.E., Schoenenberger A.J.A., et al. [Integrated pharmaceutical care programme in patients with chronic diseases]. Farm Hosp (1130- 6343). 2012 Jul-Aug; 36(4):
229–39.
Gourley G.A., Portner T.S., Gourley D.R., Rigolosi E.L., Holt J.M., Solomon D.K., et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;38(5):586–97.
Granger-Rousseau T.J., McElnay J.C. A model for community pharmacist involvement with general practitioners in the management of asthma patients. J Appl Ther 1997; 1: 145–61.
Gruppo di lavoro OsMed. L’uso dei farmaci in Italia, Rapporto nazionale anno 2011, Roma, Il Pensiero Scientifico Editore, 2012.
Grymonpre R.E., Didur C.D., Montgomery P.R., Sitar D.S.. Pill count, self- report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998 Jul-Aug; 32(7-8):749–754.
Gurwitz J.H., Rochon P.. Considerations in designing an ideal medication-use system: lessons from caring for the elderly. Am J Health Syst Pharm 2000 Mar 15; 57(6): 548-51.
Gwadry-Sridhar F.H., Manias E., Lal L., Salas M., Hughes D.A., Ratzki-Leewing A., Grubisic M.. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health 2013; 16(5):863-871.
Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., Caso P., Dudek D., Gielen S., Huber K., Omhan N., Petrie M.C., Sonntag F., Uva M.S., Storey R.F., Wijns V., Zahger D.. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes
(ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 Dec; 32(23):2999–
3054.
Hawksworth G.M., Corlett A.J., Wright D.J., Chrystyn H.. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999 Jun; 47(6):695–700.
Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X.. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008 Apr 16;
(2):CD000011.
Haynes R.B., Yao X., Degani A., Kripalani S., Garg A., McDonald H.P..
Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005; 4:CD000011.
Hedegaard U., Kjeldsen L.J., Pottegård A., Henriksen J.E., Lambrectsen J., Hangaard J., Hallas J.. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial. The American Journal Of Medicine 2015 Dec; 128(12):1351-61. doi: 10.1016/j.amjmed.2015.08.011. Epub 2015 Aug 21.
Hepler C.D., Grainger-Rousseau T.J.. Pharmaceutical care versus traditional drug treatment; is there a difference? Drugs 1995 Jan; 49(1):1–10.
Hepler C.D., Strand L.M.. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47:533-543.
Hepler C.D.. Pharmaceutical Care. Pharm World Sci 1996; 18:233–236.
Hepler C.D.. Regulating for outcomes as a systems response to the problem of drug-related morbidity. J Am Pharm Assoc (Wash) 2001 Jan-Feb; 41(1):108–
115.
Hepler C.D.. The Pharmacist in the medication use process (an Introduction to pharmaceutical care), in: Hepler C.D. editor, Pharmaceutical care in community practice. Proceedings of the Section of Community Pharmacists, Tokyo, World Congress of Pharmacy and Pharmaceutical Sciences, 1993. Hillerod, Denmark:
FIP, 1995.
Herborg H., Soendergaard B., Jorgensen T., Fonnesbaek L., Hepler C.D., Holst H., Froekjaer B.. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications. J Am Pharm Assoc (Wash.) 2001; 41(4):551–559.
Hisashige A.. The Effectiveness and Efficiency of Disease Management Programs for Patients with Chronic Diseases. Global Journal of Health Science 2013 Nov 26; 5(2):27-48.
Ho P.M., Lambert-Kerzner A., Carey E.P., Fahdi I.E., Bryson C.L., Melnyk S.D., Bosworth H.B., Radcliff B., Davis R., Mun H., Weaver J., Barnett C., Barón A., Del Giacco E.J.. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med 2014 Feb 1;
174(2):186-193.
Ho P.M., Rumsfeld J.S., Masoudi F.A., McClure D.L., Plomondon M.E., Steiner J.F., Magid D.J.. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;
166(17):1836–1841. PubMed PMID: 17000939. Epub 2006/09/27. eng.
Holdford D.A., Brown T.R.. Introduction to Hospital & Health-System Pharmacy Practice, American Society of Health-System Pharmacists, Bethesda, 2010.
Homedes N., Ugalde A.. Improving acces to pharmaceuticals in Brazil and Argentina. Health Policy Plan 2006 Mar; 21(2):123-131.
Horne R., Barber N., Weinman J., Elliott R.A., Morgan M., Cribb A..
Concordance, adherence and compliance in medicine taking: a scoping exercise, London, NHS National Coordinating Center for Service Delivery and Organisation, 2006.
Hugtenburg J.G., Borgsteede S.D., Beckeringh J.J.. Medication review and patient counselling at discharge from the hospital by community pharmacists.
Pharm World Sci 2009 Dec; 31(6):630–637.
Hussain A., Ibrahim M.I.. Medication counselling and dispensing practices at community pharmacies: a comparative cross sectional study from Pakistan. Int J Clin Pharm 2011 Oct; 33(5):859-867.a
Hussain A, Ibrahim MI.. Qualification, knowledge and experience of dispensers working at community pharmacies in Pakistan. Pharm Pract (Internet) 2011 Apr;
9(2):93-100.b
Jácome J.A., García A.I.. Estudio prospectivo sobre el impacto de un servicio de atencíon farmacéutica comunitaria en personas asmáticos. [Prospective study about the impact of a community pharmaceutical care service in patients with asthma.] Rev Esp Salud Publica 2003; 77:393–403.
Jameson J., VanNoord G., Vanderwoud K.. The impact of a pharmacotherapy consultation n the cost and outcome of medical therapy. J Fam Pract. Nov 1995;
41(5):469-‐472.
Jarab A.S., Alqudah S.G., Khdour M., Shamssain M., Mukattash T.L.. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012; 34(1):53–62.
Johnson J.A., Bootman J.L.. Drug-related morbidity and mortality: a cost-of- illness model. Arch Int Med. 1995 Oct 9; 155(18):1949-56.
Kaboli P.J., Hoth A.B., McClimon B.J., Schnipper J.L.. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166(9):955–
64.
Kafeel H., Rukh R., Naveed S.. Evalutation of patient counseling in different hospital of Karachi, Pakistan; a neglected domani of Pharmacy. International Research Journal of Pharmacy 2014; 5(3):203-206.
Kane S.L., Weber R.J., Dasta J.F.. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003 May; 29(5):691–698.
Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A.. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey. JAMA 2002 Jan 16; 287(3):337-344.
Khdour M.R., Agus A.M., Kidney J.C., Smyth B.M., Elnay J.C., Crealey G.E..
Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD. Int J Clin Pharm. 2011; 33(4):665–673.
Khdour M.R., Kidney J.C., Smyth B.M., McElnay J.C.. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009; 68(4):588–598.
Kinget R.. Put community pharmacy on a brand new track. Int Pharm J 2000;
14:4–7.
Knowlton C.H., Penna R.P.. Pharmaceutical care, New York, Chapmna &Hall 2nd edition, 2003.
Kocken G.A.. Medication discussion groups in the Netherlands: five years of experience. Med Educ 1999 May; 33(5):390–393.
Koshman S.L., Charrois T.L., Simpson S.H., McAlister F.A., Tsuyuki R.T..
Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008; 168(7):687–694.
Kraemer D.F., Kradjan W.A., Bianco T.M., Low J.A.. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J Pharm Pract 2012 Apr;
25(2):169–179.
Krska J, Manfrin A.. Pharmacist and GP views on a medicine use review pilot project conducted in Italy [abstract]. Research in Social and Administrative Pharmacy (2004) 2014 Sep-Oct; 10(5):e38 doi:10.1016/j.sapharm.2014.07.100.
Kuhmmer R., Margarites L.K., Antonini Ribeiro R., Serpa H.L, Nader Bastos G.A., Schardosim Cotta de Souza M.C., Polanczyk C.A., Flores Soares Rollin A., Caon S., Moreira G., Leite L.E.A., Scholante Delabray T., Falavigna M..
Effectiveness of pharmaceutical care at discharge in the emergency department:
Study protocol of a randomized controlled trial. Trials 2015 Feb 25; 16:60.
Kuo G.M., Touchette D.R., Marinac J.S.. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study. Pharmacotherapy 2013 Mar; 33(3):253–265.
Lambert M., Conus P., Eide P., Mass R., Karow A., Moritz S., Golks D., Naber D.. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry 2004 Nov, 19(7):415-422.
LaPointe N.M., Jollis J.G.. Medication errors in hospitalized cardiovascular patients. Arch Intern Med 2003 Jun 23; 163(12):1461–1466.
Lee A.J., Borham A., Korman N.E., Keeney B.E., Mock E.D.. Staff development in pharmacist-conducted patient education and counselling. Am J Health Syst Pharm. 1998; 55(17):1792–1798.
Leemans L., Veroeveren L., Buelens J., Hendrickx C., Keyenberg W., Niesten F., Vandeberg J., Van Hoof J., Laekeman G.. Frequency and trends of interventions on pre- scriptions in Flemish pharmacies. Pharm World Sci 2003 Apr; 25(2):65–
69.
Li Z., Fang Z., Ge M., Yang R., Zhu Y.. Effects of integrated pharmaceutical care on patients with chronic obstructive pulmonary disease in community. Chin J Gen Pract. 2010; 8(12):1561–1563.
Lin H., Wu X. (2014) Intervention Strategies for Improving Patient Adherence to Follow-Up in the Era of Mobile Information Technology: A Systematic Review and Meta-Analysis. PLoS ONE 2014 Aug 6; 9(8):e104266. doi:
10.1371/journal.pone.0104266. eCollection 2014.
Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y.. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009
;119(3):e182.
Lloyd-Jones D.M., Hong Y., Labarthe D., Mozaffarian D., Appel L.J., Van Horn L., Greenlund K., Daniels S., Nichol G., Tomaselli G.F., Arnet D.K., Fonarow G.C., Ho P.M., Lauer M.S., Frederick A.M., Robertson R.M., Roger V.,
Schwamm L.H., Sorlie P., Yancy C.W., Rosamond W.D.. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
Circulation 2010; 121(4):586–613.
Lo Scalzo A., Donatini A., Orzella L., Cicchetti A., Profi li S., Maresso A.. Italy:
Health system review. Health Systems in Transition 2009; 11(6):1-216.
López Cabezas C., Falces Salvador C., Cubí Quadrada D., Arnau Bartés A., Ylla Boré M., Muro Perea N., Homs Peipoch E.. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp 2006; 30(6):328-342.
Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Bohm M, et al.
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.
Manfrin A, Caparrotta L, Krska J.. Evaluation of a pilot study involving MUR provision in Italy, using web-based data capture [abstract]. Int J Pharma Practice 2013; 21 Suppl 2:113–114.a
Manfrin A, Caparrotta L, Krska J.. Medicine Use Review pilot project in Italy.
Full report sent to FOFI (Italian Pharmacists’ Federation). 2013.b
Manfrin A, Krska J.. Evaluation of feedback on medicines use reviews provided in Italy from patients with asthma [abstract]. Research in Social and Administrative Pharmacy 2014; doi:10.1016/j.sapharm.2014.07.062.
Manfrin A., Thomas T., Krska J.. Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-
MUR). BMC Health Serv Res 2015 Apr 21; 15:171.a doi: 10.1186/s12913-015- 0791-6.
Manfrin A., Thomas T., Krska J.. Valutazione randomizzata della revisione italiana dell’uso dei farmaci fornita nella farmacia di comunità utilizzando l’asma come modello (RE I-MUR). Riassunto esecutivo. www.mnlf.it Ottobre
2015. Accessed 8 Marzo 2016.b URL
http://www.mnlf.it/focus/107/files/RicercaFOFI.pdf
Márquez-Contreras E., Martell-Claros N., Gil-Guillén V., de la Figuera-Von W.M., Casado-Martínez J.J., Martin-de Pablos J.L., Figueras M., Galera J., Serra A., Compliance group of the spanish society of Hypertention (SEE). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006; 24(1):169–75.
Martín-Calero M.J., Machuca M., Murillo M.D., Cansino J., Gastelurrutia, Faus M.J.. Structural Process and Implementation Programs of Pharmaceutical Care in Different Countries. Current Pharmaceutical Design 2004; 10(31):3969-3985.
McDonough R.P., Pithan E.S., Doucette W.R. Brownlee MJ.. Marketing Pharmaceutical Care Services. J Am Pharm Assoc 1998; 38:667-681.
McFarlane S.I., Jacober S.J., Winer N., Kaur J., Castro J.P., Wui M.A., Gliva A., Von Gizycki H., Sowers J.R.. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002 Apr; 25(4):718–723.
McGivney M.S., Meyer S.M.., Duncan–Hewitt W., Hall D.L., Goode Jean- Venable R., Smith R.B.. Medication therapy management: ITS relationship to patient counseling, disease management, and pharmaceutical care. Journal of The American Pharmacists Association (2003) 2007 Sep-Oct; 47(5):620-628.
McLean D.L., McAlister F.A., Johnson J.A., King K.M., Makowsky M.J., Jones C.A., Tsuyuki R.T., SCRIP-HTN Investigators. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk in- tervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 2008 Nov 24;
168(21):2355–2361.
Menzin J., Wygant G., Hauch O., Jackel J., Friedman M.. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin 2008; 24(2):461–
468.
Morisky D.E., Green L.W., Levine D.M.. Concurrent and predictive validity of a self- reported measure of medication adherence. Med Care 1986 Jan; 24(1):67–
74.
Morisky D.E., Levine D.M., Green L.W., Shapiro S., Russell R.P., Smith C.R..
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73(2):153–162.
Morris C.J., Cantrill J.A., Hepler C.D., Noyce P.R.. Preventing drug-related morbidity-determining valid indicators. Int J Qual Health Care 2002; 14(3):183–
198.
Mort J.R., Aparasu R.R.. Prescribing of psychotropics in the elderly: Why is it so often inappropriate? CNS Drugs 2002; 16(2):99-109.
Muijrers P.E.M., Knotnerus J.A., Sijbrandij J., Janknegt R., Grol R.P.T.M..
Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of community pharmacists. Pharm World Sci 2003 Oct; 25(5):235–41.
Murray M.D., Young J., Hoke S., Weiner M., Morrow D., Stroupe K.T., Wu J., Clark D., Smith F., Gradus-Pizlo I., Weinberger M., Brater D.C.. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-725.
Närhi U.. Implementing the philosophy of pharmaceutical care into community pharmacy services-experiences with asthma patients in Finland [Dissertation]
Kuopion Yliopisto, Kuopio 2001. ISBN 951-781-152-7. ISSN 1235-0478.
National Council on Patient Information and Education (NCPIE). The Other Drug Problem: Statistics on Medicine Use and Compliance. Bethesda, Md; 1997
Nichols-English G., Poirier S.. Optimizing Adherence to Pharmaceutical Care Plans. J Am Pharm Assoc 2000; 40(4):475-485.
Olson K.L., Delate T., Rasmussen J., Humphries T.L., Merenich J.A., Clinical Pharmacy Cardiac Risk Service Study Group. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management. Am J Manag Care 2009; 15(8):497–503.
Page S.J., Persch A.C.. Recruitment, retention, and blinding in clinicl trials. Am JOccup Ther 2013; 67(2):154-161.
Pape G.A., Hunt J.S., Butler K.L., Siemienczuk J., LeBlanc B.H., Gillanders W., Rozenfeld Y., Bonin K.. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med 2011 Sep 12; 171(16):1480–1486.
Paulino E.I., Bouvy M.L., Gastelurrutia M.A., Buurma H., ESCP-SIR Rejkjavik Community Pharmacy Research Group. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 2004 Dec; 26(6):353–360.
Peterson A.M., Takiya L., Finley R.. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–65.
Pharmaceutical Services Negotiating Committee (PSNC 2013). Medicines use reviews and prescription intervention service. http://psnc.org.uk/wp- content/uploads/2013/06/MUR-service-spec-Aug-2013-changes_FINAL.pdf.
Accessed 7 Mar 2016.
Phumipamorn S., Pongwecharak J., Soorapan S., Pattharachayakul S.. Effects of the pharmacist’s input on glycaemic control and cardiovascular risks in Muslim diabetes. Prim Care Diabetes 2008 Feb; 2(1):31– 37.
Pirmohamed M., James S., Meakin S., Green C., Scott A.K., Walley T.J., Farrar K., Park B.K., Breckenridge A.M.. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004; 329(7456):15–9.
Planas L.G., Crosby K.M., Mitchell K.D., Farmer K.C.. Evaluation of a hypertension medication therapy management program in patients with diabetes.
J Am Pharm Assoc (2003) 2009; 49:164–170.
Plaza L., Herrera J.. The new challenge in Pharmaceutical Health Care: to reach a consensus among the professionals. Pharm Care Esp 2003; 5:160-165.
Plumridge R.J., Wojnar-Horton R.E. A review of the pharmaco-economics of pharmaceutical care. Pharmacoeconomics 1998; 14 (2):175-189.
Ponniah A., Anderson B., Shakib S., Doecke C.J., Angley M.. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther 2007 Aug; 32(4):343–352.
Portlock J, Holden M, Patel S.. A community pharmacy asthma MUR project in Hampshire and the Isle of Wight. Pharm J 2009; 282:109–12.
Posey L.M.. Proving that pharmaceutical care makes a difference in community pharmacy. Viewpoint. J Am Pharm Assoc 2003 Mar-Apr; 43(2):136-139.
Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J.. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med.
2007;176(6):532–55.
Reebye R.N., Avery A.J., Bissell P., Van Weel C.. The issue of territoriality between pharmacists and physicians in primary care. Int J Pharm Practice 2002;
10(2):69–75.
Resnick H.E., Foster G.L., Bardsley J., Ratner R.E.. Achievement of American Diabetes As- sociation clinical practice recommendations among U.S. adults with diabetes, 1999- 2002: the National Health and Nutrition Examination Survey.
Diabetes Care 2006 Mar; 29(6):531–537.
Rettenbacher M.A., Hofer A., Eder U., Hummer M., Kemmler G., Weiss E.M., Fleischhacker W.W.. Compliance in schizophrenia: psycho-pathology, side effects, and patients' attitudes toward the ill- ness and medication. Journal of Clinical Psychiatry 2004; 65:1211-1218.
Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics- 2011 update: a report from the American Heart Association. Circulation 2011;
123(4):e18-e209.
Rossing C., Holme Hansen E., Krass I.. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Adm Pharm 2001; 19:55–64.
Rothman R.L., Malone R., Bryant B., Shintani A.K., Crigler B., Dewait D.A., Dittus R.S., Weinberger M., Pignone M.P.. A randomized trial of a primary care- based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005 Mar;
118(3):276–284.
Roughead L., Semple S., Vitry A.. The value of pharmacist professional services in the community setting. A systematic review of the literature 1990 –2002, Adelaide, Quality Use of Medicines and Pharmacy Research Centre, School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, 2003.
Rovers J.P., Currie J.D., Hagel H.P., McDonough R.P., Sobotka J.L.. A practical guide to pharmaceutical care, Washington DC, American Pharmaceutical Association, 2003.
Rüütel D, Pudersell K.. Pharmaceutical Policy and the effects of the economic crisis: Estonia. Eurohealth 2011; 17(1):5-8.
Saanum D.T., Mellbye K.S.. The prescription as an aid for communication between physicians and pharmacists. A study of errors and insufficient information on prescriptions. Tidsskr Nor Laegeforen 1996 Aug 19;
116(19):2325–2329.
Sadik A., Yousif M., McElnay J.C.. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol 2005; 60(2):183-93.
Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G.. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011;
171(16):1441–1453.
Santschi V., Chiolero A., Colosimo A.L., Platt R.W., Taffe P., Burnier M., Burnand B., Paradis G.. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014 Apr; 10;3(2):e000718. doi: 10.1161/JAHA.113.000718.
Santschi V., Chiolero A., Paradis G., Colosimo A.L, Burnand B.. Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes.
Diabetes Care 2012 Dec; 35(12):2706–2717.
Sarangarm P., London M.S., Snowden S.S., Dilworth T.J., Koselke L.R., Sanchez C.O., D’angio R., Ray G.. Impact of pharmacist discharge medication therapy counseling and disease state education: Pharmacist Assisting at Routine Medical Discharge (Project PhARMD). Am J Med Qual 2013 Jul-Aug; 28(4):292–300.
Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Di Angelantonio E., Ingelsson E., Lawlor D.A., Selvin E., Stampfer M., Stehouwer C.D., Lewington S., Pennells L., Thompson A., Sattar N., White I.R., Ray K.K., Danesh J..
Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010 Jun 26; 375(9733):2215-2222. doi:
10.1016/S0140-6736(10)60484-9.
Saydah S.H., Fradkin J., Cowie C.C.. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004 Jan 21;
291(3):335–342.
Schaefer M., Kresser J.. Pharmazeutische Betreuung vermeidet Scha ̈den.
[Pharmaceutical care prevents damage]. Pharm Ztg 1998; 143:4446–4454.
Schatz M, Sorkness AC, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M., Pendergraft T.B., Jhingran P.. Asthma control test; reliability, validity and
responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006; 117(3):549–56.
Scheerder G., De Coster I., Van Audenhove C.. Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatric Services 2008 Oct; 59(10):1155-60.
Schillinger D., Piette J., Grumbach K., Wang F., Wilson C., Daher C., Leong- Grotz K., Castro C., Bindman A.B.. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003 Jan 13; 163(1):83–90.
Schrader S.L., Dressing B., Blue R., Jensen G., Miller D., Zawada E.T.. The medication reduction project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med 1996 Dec; 49(12):441-448.
Schroeder K., Fahey T., Ebrahim S.. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004; (2):CD004804.
Schulz M., Verheyen F., Muhlig S., Muller J.M., Muhlbauer K., Knop-Schneikert E., Petermann F., Bergmann K.C.. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001 Jun; 41(6):668–
676.
Scott D.M., Boyd S.T., Stephan M., Augustine S.C., Reardon T.P.. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006 Nov 1 ;63(21):2116–2122.
Simpson S.H., Majumdar S.R., Tsuyuki R.T., Lewanczuk R.Z., Spooner R., Johnson J.A.. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.
Diabetes Care 2011 Jan; 34(1):20–26. 2011 doi: 10.2337/dc10-1294. Epub 2010 Oct 7.
Siris E.S., Miller P.D., Barrett-Connor E., Faulkner K.G., Wehren L.E., Abbott T.A., Berger M.L., Santora A.C., Sherwood L.M.. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women.
Results from the National Osteoporosis Risk Assessment. JAMA 2001 Dec 12;
286(22):2815–2822.
Skaer T.L., Sclar D.A., Markowski D.J., Won J.K.. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens. 1993; 7(5):515–518.
Smith D.L.. The effect of patient non-compliance on health care costs. Med Interface 1993; 6(4):74-76,78,84.
Smith L., McGowan L., Moss-Barclay C., Wheater J., Knass D., Chrystyn H.. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol 1997 Aug; 44(2):163–165.
Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S.. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005 Jun; 43(6):521-530.
Solomon D.K., Portner T.S., Bass G.E., Gourley D.R., Gourley G.A., Holt J.M., Wicke W.R., Braden R.L., Eberle T.N., Self T.H., Lawrence B.L.. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998 Sep-Oct; 38(5):574–85.
Sondergaard B., Thorleifsson S., Herborg H., Frøkjaer B., Hepler C.D., Ersboll B.K.. Kvalitetssikring af astmapatienters lae- gemiddelbehandling,
Sundhedsøkonomisk analyse. [Quality assurance of drug therapy for patients with asthma. Health economic analysis]. Ugeskr Laeger 2000 Jan 24; 162(4):480–486.
Spencer J.A., Edwards C.. Pharmacy beyond the dispensary: general practitioners’ views. BMJ 1992 Jun 27; 304(6843):1670-1672.
Spinewine A., Fialova D., Byrne S.. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 2012 Jun 1; 29(6):495–510.
PubMed PMID: 22642783. Epub 2012/05/31. eng.
Sriram S., Chack L.E., Ramasamy R., Ghasemi A., Ravi T.K., Sabzghabaee A.M.. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. J Res Med Sci 2011 Mar; 16(Suppl 1.):S412–S418.
Stone L.. Good Pharmacy Practice in Developing Countries: Recommendations for Step-wise Implementation, The Hague: FIP Congress Report, 1998.
Stoner K.C., Ching M., Murray M.A.. Impact of a pharmaceutical care model on the management of congestive heart failure patients in a geriatric medicine teaching clinic. ASHP Annual Meeting 1998; 55:OUT-1.
Straka R.J., Taheri R., Cooper S.L., Smith J.C.. Achieving cholesterol target in a managed care organization (ACTION) trial. Pharmacotherapy 2005; 25(3):360–
371.
Strand L.M., Cipolle R.J., Morley P.C.. Pharmaceutical Care: An Introduction, Michigan, Upjohn Co, 1992, PP 14-29.
Strand L.M., Morley P.C., Cipolle R.J., Ramsey R., Lamsam G.D.. Drug-related problems; their structure and function. DICP 1990 Nov; 24(11):1093-1097.
Strand L.M., Cipolle R.J., Morley P.C., Frakes M.J.. The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient in the
Ambulatory Practice Setting: Twenty-five Years of Experience. Current Pharmaceutical Design 2004; 10(31):3987-4001.
Taveira T.H., Friedmann P.D., Cohen L.B., Dooley A.G., Khatana S.A., Pirraglia P.A., Wu W.C.. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ 2010 Jan-Feb; 36(1):109-17. doi:
10.1177/0145721709352383. Epub 2009 Dec 4.
The Pharmaceutical care of the Elderly in Europe Research (PEER) Group.
Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18(1):63-77.
Tinke J.L.. Facts and figures, cost development of pharmaceutical care. The Hague: Stichting Farmaceutische Kengetallen,1995.
Toklu H.Z., Akici A., Oktay S., Cali S., Sezen S.F., Keyer-Uysal M.. The pharmacy practice of community pharmacists in Turkey. Marmara Pharm J 2010;
14:53-60.
Toklu H.Z., Hussain A.. The changing face of pharmacy practice and the need for a new model of pharmacy education. Journal of Young Pharmacists 2013 Jun;
5(2):38-40. doi: 10.1016/j.jyp.2012.09.001. Epub 2013 Mar 30.
Tully M.P., Seston E.M.. The impact of pharmacists providing prescription review and monitoring service in ambulatory care or community practice. Ann Pharmacother 2000 Nov; 34(11):1320–1331.
Turner J., Wright E., Mendella L., Anthonisen N.. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995 Aug;108(2):394–
400.
van de Steeg-van Gompel C.H., Wensing M., De Smet P.A.. Implementation of adherence support for patients with hypertension despite antihypertensive therapy in general practice: a cluster randomized trial. Am J Hypertens 2010 Sep; 23(9):1038-45. doi: 10.1038/ajh.2010.63. Epub 2010 Apr 1.
Van der Stuyft P., De Vos P., Hildebrand K.. USA and shortage of food and medicine in Cuba. Lancet 1997 Feb 1; 349(9048):363.
van Eijk M.E.C.. Effects of outreach strategies on quality of pharmacotherapy [Dissertation] University of Utrecht, 2000. ISBN 90-5054-155-0.
Van Mil J.W.F. Pharmaceutical Care, the future of pharmacy, theory, research and practice [Thesis]. Groningen, The Netherlands: J.W.F. van Mil 1999.b
van Mil J.W.F. Pharmacy and health care. Pharm World Sci. 2002 Dec;
24(6):213.
van Mil J.W.F., Dudok van Heel M.C., Boersma M., Tromp T.F.J.. Interventions and documentation for drug-related problems in Dutch community pharmacies.
Am J Health Syst Pharm 2001 Aug 1; 58(15):1428–1431.
van Mil J.W.F., Fernandez-Llimos F.. What is ‘pharmaceutical care’ in 2013? Int J Clin Pharm 2013. (Epub 2013/01/09).
van Mil J.W.F., Mcelnay J., Tromp T.F.J.. The challenges of defining pharmaceutical care on an international level. Int J Pharm Pract. 1999; 7(4):202–
208.a
van Mil J.W.F., Schulz M. A Review of Pharmaceutical Care in Community Pharmacy in Europe. Harvard health policy review 2006; 7(1);155-168.
van Mill J.W.F., Schulz M., Tromp T.F.J.. Pharmaceutical care, European developmets in concepts, implementation, teaching, and research: a review.
Pharm World Science December 2004; 26(6):303-311.
Varma S., McElnay J.C., Hughes C.M., Passmore A.P., Varma M..
Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19(7):860–869.
Vermeire E.I.J.J., Wens J., Van Royen P., Biot Y., Hearnshaw H., Lindenmeyer A.. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005 Apr 18;
(2):CD003638.
Vervloet M., Linn A.J., van Weert J.C., de Bakker D.H., Bouvy M.L., van Dijk L.. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012; 19(5):696–704.
Yordanova S., Petkova V.. Pharmaceutical care in some european countries, Australia, Canada and USA. World Journal of Pharmacy And Pharmaceutical Sciences 2013; 2(5):2291-2308.
Yuksel N., Majumdar S.R., Biggs C., Tsuyuki R.T.. Community pharmacist- initiated screening program for osteoporosis: randomized controlled trial.
Osteoporos Int 2010 Mar; 21(3):391-8. doi: 10.1007/s00198-009-0977-z. Epub 2009 Jun 5.
Wei L., Li J., Luo H., Wei Y., Yang X., Liu L.. Effects of pharmacy service on disease analysis and quality of life of chronic obstructive pulmonary disease.
China Med Herald. 2013; 10(17):163–165.
